Skip to content

Pilot Bleeding Study: Risk and Protective Factors Associated With Bleeding in the Hemodialysis Population

Pilot Bleeding Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00182117
Enrollment
490
Registered
2005-09-16
Start date
2003-10-31
Completion date
2006-04-30
Last updated
2006-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bleeding, End Stage Renal Disease

Keywords

bleeding, end stage renal disease, antiplatelet therapy, anticoagulant therapy, hemodialysis

Brief summary

This study is examining the risk and protective factors associated with bleeding in the hemodialysis population.

Interventions

None listed

Sponsors

St. Joseph's Healthcare Hamilton
CollaboratorOTHER
Hamilton Health Sciences Corporation
Lead SponsorOTHER

Study design

Observational model
DEFINED_POPULATION
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
0 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient is undergoing hemodialysis

Exclusion criteria

* This is an observational study. No

Countries

Canada

Contacts

Primary ContactChristian G Rabbat, MD
rabbatc@mcmaster.ca905-522-1155
Backup ContactCatherine M Clase, MD
clase@mcmaster.ca905-522-1155

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026